2 terminated. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Terminated 2 |
| Phase 1 | 1 | Terminated 1 |
Follow Allogeneic Stem Cell Transplantation: new trials by email Literature Review of Allogeneic Stem Cell Transplantation trials Research Report on Allogeneic Stem Cell Transplantation
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Xylitol BSI Multisite - Reduction of Bloodstream Infections From Oral Organisms in Pediatric Stem Cell Transplant Xylitol, Placebo - Allogeneic Stem Cell Transplantation | Phase 2 | Terminated | Children's Hospital Medical Center, Cincinnati | 256 | 2023-04-04 | 2026-09-28 |
| A Study of Siremadlin Alone and in Combination With Donor Lymphocyte Infusion in Acute Myeloid Leukemia Post-allogeneic Stem Cell Transplant Siremadlin - Acute Myeloid Leukemia, Allogeneic Stem Cell Transplantation | Phase 1 / Phase 2 | Terminated | Novartis Pharmaceuticals | 8 | 2023-02-23 | 2025-05-16 |
Gingivitis (1) · Leukemia, Myeloid, Acute (1) · Mucositis (1) · Plaque, Amyloid (1) · Sepsis (1)
Digestive System Diseases (1) · Gastroenteritis (1) · Gastrointestinal Diseases (1) · Gingival Diseases (1) · Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1) · Infections (1) · Inflammation (1) · Leukemia (1) · Leukemia, Myeloid (1) · Mouth Diseases (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Pathologic Processes (1) · Pathological Conditions, Anatomical (1)
Xylitol (1) · siremadlin (1)
Children's Hospital Medical Center, Cincinnati (1) · Novartis Pharmaceuticals (1)
Germany (1) · Italy (1) · Spain (1) · United States (1)
Christopher Dandoy, MD, MSc (1)
1UG3DE030401-01 (1)